Daniel M. Siegel MD, MS, CPCDClinical Professor of Dermatology, SUNY Downstate, Brooklyn, New York
Dr. Daniel Siegel is Clinical Professor at the State University of New York at Downstate and Director of the Procedural Dermatology – Mohs Surgery Fellowship Program. He represents the specialty of Dermatology on the AMA Resource Based Relative Value Update Committee, where he chaired its standing Research Committee from 2007-2009.
Dr. Siegel was a member of the Board of Directors of the American Academy of Dermatology (executive committee 2008-2010) through March 2010 and is a director of the American College of Mohs Surgery and the Women's Dermatologic Society Women's Dermatologic Society and DebRA International, where he is past Secretary of that organization.
Dr. Siegel is a past President of the AAD (2012).
A graduate of Stuyvesant High School, Rensselaer Polytechnic Institute (BS in Biology Magna Cum Laude), Albany Medical College and the W. Averill Harriman School of Management (MS in Management and Policy), Dr. Siegel’s medical training took place at the Albany Medical Center Hospital,(Internship), Parkland Memorial Hospital, Dallas, Texas (Dermatology Residency and Chief Residency), Baylor College of Medicine, Houston, Texas (Fellowship, Mohs Micrographic Surgery and Dermatologic Surgery) .
Dr. Siegel is an editor of the exciting textbook Surgery of the Skin: Procedural Dermatology, the second edition of which was introduced at the 2010 AAD. He is the Cyberdermatology Consultant to JAAD, an Assistant Editor of Dermatologic Surgery journal, and consulting editor of Ostomy/Wound Management. He is the author of more than 90 scientific papers, editor of three additional books, and holder of one US patent. Has run multiple AAD coding courses and computer courses and currently co-chairs the AAD’s EHR session and EHR “shootouts.”
DisclosuresDr, Siegel's disclosures are as follows: Advisory board - SunDUSA and Biofrontera advisory boards.
Recent Contributions to PracticeUpdate:
- Trends in Access and Cost of Photodynamic Therapy Among US Medicare Beneficiaries
- Age at Diagnosis as a Contraindication for Intervention in Nonmelanoma Skin Cancer
- Correlation Between Original Biopsy and Mohs Intraoperative Pathology
- Surgery vs 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma